Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Oct 1 - Oct 6
Geroprotective and Anticarcinogenic Activity Lifetime Murine Studies Long-term studies in mice demonstrated that DSIP administration over a lifetime decreased total spontaneous tumour incidence 2.6-fold compared to untreated controls, slowed age-related switching-off of oestrous function, decreased the frequency of chromosome aberrations in bone marrow cells by 22.6%, and increased maximum lifespan by 24.1% compared to control groups a multi-parameter geroprotective profile that is among the most striking reported for any short regulatory peptide, and that has generated sustained interest in the DSIP analogue research field
Preliminary findings from these studies suggest a tolerable oral dosage of approximately 100mg/kg in mice [1]
However, results can vary, and no single treatment works for everyone
ULTIMA LABS Premium Research Grade Peptides Secure Payments Legal Privacy Policy Terms & Conditions Returns Policy Disclaimer Policy Support Shipping Policy FAQ Contact Us Company About Us Research Vote Affiliates Wholesale ULTIMA RESEARCH TECHNOLOGIES CORPORATION LTD 2025
US$ 26.36
:max_bytes(150000):strip_icc()/benefits-of-glutathione-89457_final-01-502464fe91b2444285b0cccf8cb0a33c.png)
US$ 24.12
US$ 29.28
US$ 24.92
US$ 22.67
US$ 29.80
